|
Species |
# of Strains Tested |
MIC in micrograms/ml |
|
Staphylococcus aureus (methicillin resistant) |
97 |
64-128 |
|
Coagulase-negative staphylococci |
20 |
16 |
|
Streptococcus pyogenes |
20 |
8-128 |
|
Enterococci |
20 |
32-128 |
|
Candida Albicans |
20 |
64 |
|
Escheri coli |
20 |
16-32 |
|
Klebsiella pnemoniae |
20 |
32-128 |
|
Enterobacter spp. |
20 |
64-128 |
|
Pseudomonas aeruginosa |
20 |
16-32 |
|
Numerous details of experimental procedures were omitted in the 12 publications describing the in vitro effectiveness of silver sulphadiazine between 1973 and 1991, and this casts doubt on the numerical results obtained. (18) de Boer, P., and Collinson, P.O. 1981. The use of silver sulphadiazine occlusive dressings for finger-tip injuries. The Journal of Bone and Joint Surgery, 63B(4), 545-547. (19) (20) Coward, Joe E., Carr, Howard S., and Rosenkranz, Herbert S. 1973. Silver sulfadiazine: effect on the growth and ultrastructure of Staphylococci. Chemotherapy 19, 348-353. |
|
Species |
Strain No. |
AgSu, MIC, micrograms per milliliter |
GM |
CF |
AM |
Te |
C |
Pen |
E |
L |
M |
Su |
|
S. aureus |
1217 |
3.13 |
S |
S |
R |
S |
S |
R |
S |
S |
S |
S |
|
S. aureus |
1222 |
25.0 |
S |
S |
R |
R |
S |
R |
R |
R |
S |
S |
|
S. aureus |
1223 |
25.0 |
S |
S |
R |
S |
S |
R |
S |
S |
S |
S |
|
S. aureus |
1255 |
<0.78 |
S |
R |
R |
S |
S |
R |
R |
R |
R |
R |
|
S. aureus |
1293 |
3.13 |
S |
S |
R |
S |
R |
R |
S |
R |
S |
S |
|
S. epidermis |
1575 |
3.13 |
S |
S |
S |
R |
R |
R |
S |
S |
S |
R |
|
S. epidermis |
1593 |
3.13 |
S |
S |
R |
R |
R |
R |
R |
R |
R |
R |
|
Abbreviations: MIC= minimal inhibitory concentration; S= sensitive; R= resistant; AgSu= silver sulfadiazine; |
|
(21) Kulick, Michael I., et al. 1985. Prospective study of side effects associated with the use of silver sulfadiazine in severely burned patients. Annals of Plastic Surgery, 14(5), 407-419. (22) Modak, Shanta M., and Fox, Charles L. Jr. 1973. Binding of silver sulfadiazine to the cellular components of Pseudonomas aeruginosa. Biochemical Pharmacology, 22, 2391-2404. (23) Chambers, Cecil W., Proctor, Charles M., and Kabler, Paul W. 1962. Bactericidal effect of low concentrations of silver. Journal of the American Water Works Association, 208-216. (24) Wysor, M.S., and Zollinhofer, R.E. 1973. Silver phosphanilamidopyrimidine. Chemotherapy, 18, 342-347. (25) Kawahara, K., et al. 2000. Antibacterial effect of silver-zeolite on oral bacteria under anaerobic conditions. Dental Materials, 16, 452-455. (26) Hamilton-Miller, J.M.T, and Shah, Saroji. 1996. A microbiological assessment of silver fusidate, a novel topical antimicrobial agent. International Journal of Antimicrobial Agents, 7, 97-99. The table below summarizes some of the test results. |
|
Species [no. tested] |
Antimicrobial Compound |
MIC (mg/l) |
|
S. pyogenes [20] |
Silver fusidate |
4-16 |
|
|
Silver sulphadiazine |
4-64 |
|
Enterococci [20] |
Silver fusidate |
0.5-8 |
|
|
Silver sulphadiazine |
4-64 |
|
Enterobacter spp. [20] |
Silver fusidate |
32-64 |
|
|
Silver sulphadiazine |
32>128 |
|
K. pnemoniae [20] |
Silver fusidate |
32>128 |
|
|
Silver sulphadiazine |
32-64 |
|
Acinetobacter spp. [20] |
Silver fusidate |
4-32 |
|
|
Silver sulphadiazine |
4-16 |
|
Ps. Aeruginosa [20] |
Silver fusidate |
32 |
|
|
Silver sulphadiazine |
16-32 |
|
Pr. Mirabilis [20] |
Silver fusidate |
32 |
|
|
Silver sulphadiazine |
16-32 |
|
Prov. Stuartii [20] |
Silver fusidate |
32 |
|
|
Silver sulphadiazine |
16-32 |
|
Prov. Morganii [15] |
Silver fusidate |
32 |
|
|
Silver sulphadiazine |
16-32 |
|
Pr. Vulgaris [5] |
Silver fusidate |
32 |
|
|
Silver sulphadiazine |
16-32 |
|
Candida albicans [20] |
Silver fusidate |
128 |
|
|
Silver sulphadiazine |
64 |
|
(27) (28) Speck, William T., and Rosenkranz, Herbert S. 1974. Activity of silver sulphadiazine against dermatophytes. The Lancet, 895-896. |
|
Species |
MIC (micrograms of SSD/ml) in a liquid medium |
MIC (Micrograms of SSD/ml) in a plate assay |
|
Microsporum audouinii |
100 |
25 |
|
Microsporum canis |
100 |
50 |
|
Microsporum ferrugineum |
100 |
- |
|
Trichophyton violaceum |
50 |
50 |
|
Trichophyton verrucosum |
50 |
50 |
|
Epidermophyton floccosum |
1.6 |
50 |
|
(29) Wlodkowski, Theodore J., and Rosenkranz, Herbert S. 1973. Antifungal activity of silver sulfadiazine. The Lancet, 739-740. |
|
Species |
MIC (micrograms of silver sulfadiazine per milliliter) |
|
Aspergillus fumigatus |
100 |
|
Mucor pusillus |
50 |
|
Rhizopus nigricans |
100 |
|
None of the strains was inhibited by sodium sulfadiazine. |
|
(30) Miller, Lawrence P., and McCallan, S.E.A. 1957. Toxic action of metal ions to fungus spores. Agricultural and Food Chemistry, 5(2), 116-122. (31) Slade, S.J., and Pegg, G.F. 1993. The effect of silver and other metal ions on the in vitro growth of root-rotting Phytophthora and other fungal species. Annals of Applied Biology, 122, 233-251. (32) Scalzo, M., et al. 1996. Antimicrobial activity of electrochemical silver ions in nonionic surfactant solutions and in model dispersions. Journal of Pharmacy and Pharmacology, 48, 60-63. (33) Chang, Te-Wen, and Weinstein, Louis. 1975. In vitro activity of silver sulfadiazine against Herpesvirus hominis. The Journal of Infectious Diseases, 132(1), 79-81. (34) Chang, Te-Wen, and Weinstein, Louis. 1975. Prevention of Herpes Keratoconjunctivitus in rabbits by silver sulfadiazine. Antimicrobial Agents and Chemotherapy, 8(6), 677-678. (35) Tokumaru, T., (36) Chang, Te-Wen, and Weinstein, Louis. 1975. Inactivation of Treponema pallidum by silver sulfadiazine. Antimicrobial Agents and Chemotherapy, 7(5), 538-539. (37) Montes, Leopoldo F., Muchinik, Guillermo, and Fox, Charles L. 1986. Response of varicella zoster virus and herpes zoster to silver sulfadiazine. Cutis, 38, 363-365. (38) Hussain, Saber, Anner, Rolf M., and Anner, Beatrice M. 1992. Cysteine protects Na, K-ATPase and isolated human lymphocytes from silver toxicity. Biochemical and Biophysical Research Communications, 189(3), 1444-1449. (39) (40) (41) Simonetti, N., et al. 1992. Electrochemical Ag+ for preservative use. Applied and Environmental Microbiology, 58(12), 3834-3836. (42) Bosetti, M., et al. 2002. Silver coated materials for external fixation devices: in vitro biocompatibility and genotoxicity. Biomaterials, 23, 887-892. (43) Deitch, Edwin A., et al. 1983. Silver-nylon: a new antimicrobial agent. Antimicrobial Agents and Chemotherapy, 23(3), 356-359. (44) Marino, Andrew A., et al. 1984. Electrical augmentation of the antimicrobial activity of silver-nylon fabrics. Journal of Biological Physics, 12, 93-98. (45) Tsai, W.C., et al. 1987. In vitro quantitative study of newly made antibacterial braided nylon sutures. Surgery, Gynecology & Obstetrics, 165, 207-211. (46) Falcone, Alfred E., and Spadaro, Joseph A. 1986. Inhibitory effects of electrically activated silver material on cutaneous wound bacteria. Plastic and Reconstructive Surgery, 77(3), 455-458. |